ABOS (Acumen Pharmaceuticals, Inc) Forvard P/S multiplikatori
Acumen Pharmaceuticals (ABOS) kompaniyasining forward P/S ko'rsatkichi biznesni baholash tendentsiyasini aks ettiradi, bunda qiymati metrika darajasini belgilaydi. Monoklonal antitelalarning patent portfeli va Altsgeymer terapiyasiga bo'lgan barqaror talab kelgusidagi pul oqimi uchun imkoniyatlar yaratadi. Neyrobiologlarning kuchli jamoasi saxovatli R&D moliyalashtirishi bilan qo'llab-quvvatlanmoqda. Biroq, tijorat mahsulotlarining yo'qligi kompaniyani joriy operatsion foydasiz ilmiy yutuqlarga bog'liq holda qoldiradi.
Acumen Pharmaceuticals, Inc (ABOS) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- biznesning bozor baholash ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Acumen Pharmaceuticals|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Acumen Pharmaceuticals|ABOS - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Acumen Pharmaceuticals, Inc|ABOS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Acumen Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi acumenpharm.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
ABOS - Sof foyda|Kelajakdagi foyda Acumen Pharmaceuticals|ABOS - Bozor narxining sof foydaga nisbati|Forvard P/E multiplikatori Acumen Pharma|ABOS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|EV/EBITDA multiplikatori Acumen Pharmaceuticals, Inc|ABOS - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Acumen Pharmaceuticals|ABOS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi acumenpharm.com|ABOS - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Acumen Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:Acumen Pharmaceuticals, Inc. ABOS
Uzoq muddatli kirish paytida xatarlarni minimallashtirish uchun bozor kapitalizatsiyasini 10-K/10-Q hisobotlaridagi prognoz qilingan daromadlar bilan bog'lash zarur bo'lib, bu prognoz qilingan P/S tendentsiyasi orqali aktivlarning haddan tashqari qimmat baholanganligini aniqlash imkonini beradi. Acumen Pharmaceuticals (ABOS) uchun ushbu ko'rsatkich fundamental barqarorlikni tasdiqlaydi, chunki eksklyuziv antitanachi patentlari va FDA ning yuqori to'siqlari kelajakdagi pul oqimlarini raqobatdan himoya qiladi.
Acumen Pharmaceuticals (ABOS) raqobatchilari
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|NBIX (Neurocrine) - Kelajakdagi narxning daromadga nisbati|Regencell - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Corp)|ACAD: Forvard P/S multiplikatori|xenon-pharma.com (XENE) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Viking Therapeutics, Inc.|SUPN: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|Forvard narx/daromad multiplikatori Denali Corp DNLI|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Forvard P/S multiplikatori biohavenpharma.com BHVN|Amylyx Pharmaceuticals, Inc. - Forvard P/S multiplikatori|Trevi Therapeutics Inc (TRVI) - Forvard narx/daromad multiplikatori|PRAX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Anavex Life Sciences Corp (AVXL)|Forvard narx/daromad multiplikatori CBLL|Forvard P/S multiplikatori Prothena Corporation|Forvard narx/daromad multiplikatori ALEC (Alector, Inc.)|Narxning kutilayotgan daromadga nisbati ANNX|Forvard P/S multiplikatori OMER (Omeros)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurogene Therapeutics (NGNE)|AC Immune - Forvard P/S multiplikatori|voyagertherapeutics.com (VYGR) - Forvard narx/daromad multiplikatori|NMRA: Forvard P/S multiplikatori|Scilex Holding (SCLX) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Tevogen Bio Holdings, Inc.|Narxning prognoz qilingan daromadga nisbati ACOG|Narxning prognoz qilingan daromadga nisbati Cognition Therapeutics (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati inhibikase.com|Forvard P/S multiplikatori SAVA (Cassava Sciences)|Forvard P/S multiplikatori Assertio Holdings ASRT|Coya - Forvard P/S multiplikatori|VTGN: Narxning prognoz qilingan daromadga nisbati|ovidrx.com (OVID) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati cervomed.com (CRVO)|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Ltd.|Clene Nanomedicine (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati PepGen Inc. (PEPG)|Jupiter Neurosciences, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori RLMD (Relmada Therapeutics)|annovisbio.com (ANVS) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|GRCE: Forvard narx/daromad multiplikatori|AIFF - Forvard P/S multiplikatori|anewmeds.com (KLTO) - Narxning prognoz qilingan daromadga nisbati|NeuroSense Therapeutics Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals|Bozor kapitallashuvining kelajakdagi daromadga nisbati MetaVia, Inc. MTVA|Forvard P/S multiplikatori NRXS|Forvard P/S multiplikatori heliusmedical.com (HSDT)|Forvard P/S multiplikatori PASG (Passage Bio)|NEUP - Forvard narx/daromad multiplikatori|NERV: Forvard narx/daromad multiplikatori|ATHA - Forvard P/S multiplikatori|Addex Therapeutics Ltd (ADXN) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Alzamend Neuro|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Protagenic PTIX|Narxning prognoz qilingan daromadga nisbati Pasithea Therapeutics (KTTA)|cortigent.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Avenue Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx BCLI|CARA - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CHRO|ELYM: Forvard P/S multiplikatori|Intra-Cellular Therapies, Inc. - Sotuvga nisbatan forvard narx|LBPH (Longboard Pharmaceuticals, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Marinus Pharmaceuticals Inc|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NRBO (NeuroBo Pharma) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Sage Therapeutics, Inc. SAGE|SNPX - Forvard narx/daromad multiplikatori|Trevena - Forvard P/S multiplikatori|VIGL - Forvard P/S multiplikatori|WENA: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cerevel Corp
